Terms: = Colorectal cancer AND PDCD1LG2, Q9BQ51, 80380, ENSG00000197646, MGC142240, Btdc, PDCD1L2, CD273, B7DC, MGC142238, PD-L2, PDL2, bA574F11_2 AND Clinical Outcome
903 results:
1. Impact of Neoadjuvant Radiochemotherapy on Pathological Complete Response for Locally Advanced Rectal cancer: A Mono Institutional Experience.
Lucarelli M; Gentile V; Bonelli R; Pasquale G; Pizzi AD; Nicola MD; Porreca A; Genovesi D
In Vivo; 2024; 38(3):1367-1374. PubMed ID: 38688610
[TBL] [Abstract] [Full Text] [Related]
2. Spreading Through Air Spaces And Thinking About Lung Metastases.
M Castro P; Rei J; Silva C; Miranda J; Guerra M
Port J Card Thorac Vasc Surg; 2023 Oct; 30(3):31-35. PubMed ID: 38499034
[TBL] [Abstract] [Full Text] [Related]
3. Application Value of High-Quality Nursing in Operating Room in Rectal cancer Operation and its Influence on Postoperative Rehabilitation.
Liu J; Tan F; Zhang Y; Zhou P; Qian Q; He Q; Xu J
Surg Innov; 2024 Jun; 31(3):274-285. PubMed ID: 38468453
[TBL] [Abstract] [Full Text] [Related]
4. Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors.
Kim JY; Kim J; Kim YI; Yang DH; Yoo C; Park IJ; Ryoo BY; Ryu JS; Hong SM
Sci Rep; 2024 Feb; 14(1):4047. PubMed ID: 38374188
[TBL] [Abstract] [Full Text] [Related]
5. EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells.
Cuenca-Escalona J; Subtil B; Garcia-Perez A; Cambi A; de Vries IJM; Flórez-Grau G
Front Immunol; 2024; 15():1355769. PubMed ID: 38343540
[TBL] [Abstract] [Full Text] [Related]
6. [clinical outcome of Five Patients with Perforated colorectal cancer].
Jinushi K; Ikenaga M; Odagiri K; Yanagimoto Y; Yamashita M; Takeyama H; Suzuki Y; Kawase T; Shimizu J; Imamura H; Dono K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1566-1568. PubMed ID: 38303343
[TBL] [Abstract] [Full Text] [Related]
7. Smartphone applications for nutrition Support: A systematic review of the target outcomes and main functionalities.
Pala D; Petrini G; Bosoni P; Larizza C; Quaglini S; Lanzola G
Int J Med Inform; 2024 Apr; 184():105351. PubMed ID: 38295584
[TBL] [Abstract] [Full Text] [Related]
8. Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?
Herrera-Martínez AD; Román ÁR; Corrales EP; Idrobo C; Ramírez PP; Rojas PM; Lázaro CR; Araujo-Castro M
Front Endocrinol (Lausanne); 2023; 14():1335202. PubMed ID: 38264281
[TBL] [Abstract] [Full Text] [Related]
9. p21 as a Predictor and Prognostic Indicator of clinical outcome in Rectal cancer Patients.
Ooi LC; Ho V; Zhu JZ; Lim S; Chung L; Abubakar A; Rutland T; Chua W; Ng W; Lee M; Morgan M; MacKenzie S; Lee CS
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255799
[TBL] [Abstract] [Full Text] [Related]
10. Nuclear pore protein POM121 regulates subcellular localization and transcriptional activity of PPARγ.
Yu Y; Farooq MS; Eberhart Meessen S; Jiang Y; Kato D; Zhan T; Weiss C; Seger R; Kang W; Zhang X; Yu J; Ebert MPA; Burgermeister E
Cell Death Dis; 2024 Jan; 15(1):7. PubMed ID: 38177114
[TBL] [Abstract] [Full Text] [Related]
11. The age-related obesity paradigm: results from two large prospective cohort studies.
Ge YZ; Liu T; Deng L; Zhang Q; Liu CA; Ruan GT; Xie HL; Song MM; Lin SQ; Yao QH; Shen X; Shi HP;
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):442-452. PubMed ID: 38146198
[TBL] [Abstract] [Full Text] [Related]
12. Transanal minimally invasive surgery for benign and malignant rectal lesions: midterm outcomes from a tertiary center.
Al-Dhaheri M; Al-Ishaq F; Toffaha A; Nada MA; Parvaiz A; Kurer M
Ann Saudi Med; 2023; 43(6):348-351. PubMed ID: 38071443
[TBL] [Abstract] [Full Text] [Related]
13. Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting.
Saberzadeh-Ardestani B; Jones JC; McWilliams RR; Tougeron D; Halfdanarson TR; Guimbaud R; Hubbard JM; Flecchia C; Shi Q; Alouani E; Sonbol MB; Ticku J; Jin Z; Taieb J; Sinicrope FA
Eur J Cancer; 2024 Jan; 196():113433. PubMed ID: 37979306
[TBL] [Abstract] [Full Text] [Related]
14. N6-methyladenosine reader protein IGF2BP1 suppresses CD8 + T cells-mediated tumor cytotoxicity and apoptosis in colon cancer.
Peng Y; Zhang Z; Yang G; Dai Z; Cai X; Liu Z; Yun Q; Xu L
Apoptosis; 2024 Apr; 29(3-4):331-343. PubMed ID: 37848671
[TBL] [Abstract] [Full Text] [Related]
15. Delayed-Onset Organ/Space Surgical Site Infection Worsens Prognosis in High-Risk Stage II and III colorectal cancer.
Okui J; Shigeta K; Kato Y; Mizuno S; Sugiura K; Seo Y; Nakadai J; Baba H; Kikuchi H; Hirata A; Makino A; Kondo T; Matsui S; Seishima R; Okabayashi K; Obara H; Sato Y; Kitagawa Y
J Gastrointest Surg; 2023 Nov; 27(11):2515-2525. PubMed ID: 37740145
[TBL] [Abstract] [Full Text] [Related]
16. Curative pelvic exenteration: initial experience and clinical outcome.
Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F
Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871
[TBL] [Abstract] [Full Text] [Related]
17. Autologous natural killer cells as a promising immunotherapy for locally advanced colon adenocarcinoma: Three years follow-up of resectable case.
Bagus BI
Cancer Rep (Hoboken); 2023 Sep; 6(9):e1866. PubMed ID: 37439389
[TBL] [Abstract] [Full Text] [Related]
18. Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer.
Ryoo SB; Heo S; Lim Y; Lee W; Cho SH; Ahn J; Kang JK; Kim SY; Kim HP; Bang D; Kang SB; Yu CS; Oh ST; Park JW; Jeong SY; Kim YJ; Park KJ; Han SW; Kim TY
Br J Cancer; 2023 Aug; 129(2):374-381. PubMed ID: 37280413
[TBL] [Abstract] [Full Text] [Related]
19. Generate Analysis-Ready Data for Real-world Evidence: Tutorial for Harnessing Electronic Health Records With Advanced Informatic Technologies.
Hou J; Zhao R; Gronsbell J; Lin Y; Bonzel CL; Zeng Q; Zhang S; Beaulieu-Jones BK; Weber GM; Jemielita T; Wan SS; Hong C; Cai T; Wen J; Ayakulangara Panickan V; Liaw KL; Liao K; Cai T
J Med Internet Res; 2023 May; 25():e45662. PubMed ID: 37227772
[TBL] [Abstract] [Full Text] [Related]
20. Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study.
Jensen LH; Rogatto SR; Lindebjerg J; Havelund B; Abildgaard C; do Canto LM; Vagn-Hansen C; Dam C; Rafaelsen S; Hansen TF
J Exp Clin Cancer Res; 2023 May; 42(1):115. PubMed ID: 37143108
[TBL] [Abstract] [Full Text] [Related]
[Next]
